2-85663170-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000542.5(SFTPB):​c.1002+176A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.459 in 152,084 control chromosomes in the GnomAD database, including 18,682 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.46 ( 18682 hom., cov: 33)

Consequence

SFTPB
NM_000542.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -2.20

Publications

18 publications found
Variant links:
Genes affected
SFTPB (HGNC:10801): (surfactant protein B) This gene encodes the pulmonary-associated surfactant protein B (SPB), an amphipathic surfactant protein essential for lung function and homeostasis after birth. Pulmonary surfactant is a surface-active lipoprotein complex composed of 90% lipids and 10% proteins which include plasma proteins and apolipoproteins SPA, SPB, SPC and SPD. The surfactant is secreted by the alveolar cells of the lung and maintains the stability of pulmonary tissue by reducing the surface tension of fluids that coat the lung. The SPB enhances the rate of spreading and increases the stability of surfactant monolayers in vitro. Multiple mutations in this gene have been identified, which cause pulmonary surfactant metabolism dysfunction type 1, also called pulmonary alveolar proteinosis due to surfactant protein B deficiency, and are associated with fatal respiratory distress in the neonatal period. Alternatively spliced transcript variants encoding the same protein have been identified.[provided by RefSeq, Feb 2010]
SFTPB Gene-Disease associations (from GenCC):
  • surfactant metabolism dysfunction, pulmonary, 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 2-85663170-T-C is Benign according to our data. Variant chr2-85663170-T-C is described in ClinVar as Benign. ClinVar VariationId is 1272295.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.742 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SFTPBNM_000542.5 linkc.1002+176A>G intron_variant Intron 8 of 10 ENST00000519937.7 NP_000533.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SFTPBENST00000519937.7 linkc.1002+176A>G intron_variant Intron 8 of 10 1 NM_000542.5 ENSP00000428719.2

Frequencies

GnomAD3 genomes
AF:
0.459
AC:
69686
AN:
151966
Hom.:
18628
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.749
Gnomad AMI
AF:
0.271
Gnomad AMR
AF:
0.412
Gnomad ASJ
AF:
0.297
Gnomad EAS
AF:
0.339
Gnomad SAS
AF:
0.318
Gnomad FIN
AF:
0.277
Gnomad MID
AF:
0.411
Gnomad NFE
AF:
0.351
Gnomad OTH
AF:
0.436
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.459
AC:
69802
AN:
152084
Hom.:
18682
Cov.:
33
AF XY:
0.453
AC XY:
33665
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.749
AC:
31100
AN:
41500
American (AMR)
AF:
0.413
AC:
6300
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.297
AC:
1029
AN:
3466
East Asian (EAS)
AF:
0.339
AC:
1755
AN:
5172
South Asian (SAS)
AF:
0.319
AC:
1538
AN:
4828
European-Finnish (FIN)
AF:
0.277
AC:
2931
AN:
10582
Middle Eastern (MID)
AF:
0.415
AC:
122
AN:
294
European-Non Finnish (NFE)
AF:
0.351
AC:
23857
AN:
67948
Other (OTH)
AF:
0.437
AC:
923
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1705
3409
5114
6818
8523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
604
1208
1812
2416
3020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.417
Hom.:
3126
Bravo
AF:
0.481
Asia WGS
AF:
0.382
AC:
1330
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Dec 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.64
DANN
Benign
0.45
PhyloP100
-2.2
PromoterAI
0.016
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2118177; hg19: chr2-85890293; COSMIC: COSV60893505; COSMIC: COSV60893505; API